Samsca
$ 275,00 – $ 660,00Price range: $ 275,00 through $ 660,00
Sartel
$ 75,00 – $ 288,00Price range: $ 75,00 through $ 288,00
Sarafem
$ 40,00 – $ 387,00Price range: $ 40,00 through $ 387,00
Sarafem is a selective serotonin reuptake inhibitor (SSRI) specifically indicated for the treatment of Premenstrual Dysphoric Disorder (PMDD). This medication helps manage the severe emotional symptoms associated with PMDD, including significant mood swings, irritability, and feelings of depression. It also effectively addresses physical discomforts such as bloating and breast tenderness that often occur in the days leading up to the menstrual cycle. By stabilizing serotonin levels, the formula works to improve daily functioning and overall quality of life during the luteal phase. Sarafem offers a targeted therapeutic approach for women seeking relief from the intense monthly distress caused by this clinical condition.
Active substance: Fluoxetine
SKU:
Sarafem
Category: Woman's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Sarafem belongs to a class of medications known as selective serotonin reuptake inhibitors (SSRIs). It is a prescription medication indicated specifically for the management of premenstrual dysphoric disorder (PMDD) in adult women. Proper therapeutic use requires careful medical evaluation and oversight by a licensed healthcare provider in accordance with federal regulations.
Understanding the proper administration, pharmacodynamics, and potential safety risks associated with Sarafem is essential for optimal treatment outcomes. Below is a comprehensive medical reference detailing its pharmacologic profile, dosing protocols, and precaution parameters.
| Parameter | Details |
|---|---|
| Active ingredient (INN) | Fluoxetine hydrochloride |
| Therapeutic class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Dosage form | Oral capsule, oral tablet |
| Route of administration | Oral |
| Primary purpose | Treatment of Premenstrual Dysphoric Disorder (PMDD) |
| Prescription status | Prescription only (Rx) |
Main uses
Sarafem is approved by the US Food and Drug Administration (FDA) for the treatment of premenstrual dysphoric disorder (PMDD). PMDD is a severe form of premenstrual syndrome characterized by marked mood disturbances, intense emotional distress, severe irritability, and functional impairment occurring during the luteal phase of the menstrual cycle. Clinical diagnosis requires distinct criteria outlined in standard diagnostic manuals. While fluoxetine, the active ingredient in Sarafem, is prescribed under other trade names for major depressive disorder, obsessive-compulsive disorder, and panic disorder, Sarafem is formulated and marketed specifically for PMDD management. Off-label use for non-approved conditions must be determined solely by a qualified prescriber based on individualized medical assessment.
How the drug works
The precise physiological mechanism of Sarafem in premenstrual dysphoric disorder is linked to its selective inhibition of central nervous system neuronal uptake of serotonin (5-HT). Fluoxetine exhibits high affinity for the serotonin transporter protein while displaying minimal binding affinity to adrenergic, cholinergic, or histaminergic receptors. By blocking serotonin reuptake into presynaptic terminal neurons, Sarafem increases extracellular concentrations of serotonin in key brain regions involved in mood regulation. In PMDD, cyclical fluctuations of reproductive hormones affect central neurotransmitter systems; stabilization of serotonergic neurotransmission during the luteal phase helps alleviate affective and physical symptoms typical of the condition.
Dosing schedule
Sarafem is administered orally. The recommended starting dose for PMDD is 20 mg daily. The prescription schedule may follow one of two clinical regimens: continuous daily dosing throughout the entire menstrual cycle, or intermittent dosing starting 14 days prior to the anticipated onset of menstruation through the first full day of menses. The dosing schedule must be individually tailored by the prescribing clinician based on patient response and symptom severity. Dosages above 20 mg daily have not been shown to provide additional efficacy in PMDD clinical trials and may increase the frequency of adverse effects. Sarafem may be taken in the morning to minimize nocturnal sleep disturbances.
What happens in the body
Following oral administration, fluoxetine hydrochloride is well absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 6 to 8 hours. Systemic bioavailability is unaffected by food ingestion. Fluoxetine is extensively bound to human plasma proteins (approximately 94.5%) and distributes widely throughout bodily tissues. Metabolism occurs primarily in the liver via the cytochrome P450 enzymatic system, specifically CYP2D6, converting fluoxetine into its active metabolite, norfluoxetine. Fluoxetine possesses an elimination half-life ranging from 1 to 3 days after acute administration, while its active metabolite norfluoxetine exhibits an elimination half-life of 7 to 15 days. Steady-state plasma concentrations are achieved after several weeks of continuous administration. Elimination occurs predominantly via hepatic metabolism followed by renal excretion of metabolites.
What to avoid while taking it
Sarafem may be taken with or without food, as food intake does not alter overall bioavailability. However, patients are advised to avoid alcohol consumption while taking Sarafem. Central nervous system depression may be potentiated when SSRIs are combined with ethanol, leading to impaired cognitive judgment, enhanced sedation, and altered psychomotor performance. Additionally, dietary supplements containing St. John’s Wort (Hypericum perforatum) must be avoided due to significant risks of pharmacodynamic interaction leading to serotonin excess.
What not to combine
Sarafem exhibits significant interaction potential with numerous drug classes. Concomitant administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the risk of life-threatening Serotonin Syndrome; a minimum 14-day wash-out period is required after discontinuing an MAOI before starting Sarafem, and at least 5 weeks must elapse after stopping Sarafem before initiating MAOI therapy. Co-administration with thioridazine or pimozide is contraindicated due to risks of severe ventricular arrhythmias and QT interval prolongation. Combining Sarafem with nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, or anticoagulants such as warfarin increases the clinical risk of upper gastrointestinal bleeding. Furthermore, because fluoxetine strongly inhibits the CYP2D6 isoenzyme, it can elevate blood levels of concomitant medications metabolized by this pathway, including tricyclic antidepressants and certain antiarrhythmics.
Adverse reactions
Clinical trials of Sarafem indicate that side effects are generally mild to moderate and often transient. Frequently reported adverse reactions include nausea, headache, fatigue, insomnia, dizziness, somnolence, decreased appetite, tremor, and sinus inflammation. Gastrointestinal symptoms such as dry mouth and diarrhea may also occur during initial weeks of therapy. Sexual dysfunction, including decreased libido, anorgasmia, and delayed ejaculation, is an established adverse effect of SSRI therapy that may persist throughout treatment. Weight changes, both modest weight loss and weight gain, have been observed. Patients experiencing persistent or intolerable side effects should consult their healthcare provider for clinical evaluation.
Important precautions
Sarafem carries a Black Box Warning regarding an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults up to age 24 during initial treatment phases. Patients of all ages should be closely monitored for clinical worsening, agitation, or unusual behavioral changes. Sarafem is not FDA-approved for pediatric patients. Caution is advised in individuals with a history of seizure disorders, bipolar disorder, angle-closure glaucoma, or significant hepatic impairment; lower or less frequent doses may be required in patients with liver dysfunction. Use during pregnancy, particularly during the third trimester, may expose newborns to risks of persistent pulmonary hypertension of the newborn (PPHN) or neonatal withdrawal symptoms. Fluoxetine is excreted in human breast milk; treatment decisions during lactation require a balanced assessment of clinical risks and therapeutic benefits.
If you skip a dose
If a dose of Sarafem is missed, it should be taken as soon as remembered on that day, unless it is close to the time for the next scheduled dose. In that scenario, skip the missed dose and resume the normal administration schedule. Patients must never double the dose to compensate for a missed capsule. Due to the prolonged half-life of fluoxetine and its active metabolite norfluoxetine, missing a single dose typically does not result in immediate withdrawal symptoms or sudden loss of therapeutic efficacy.
Red flags
Immediate emergency medical care is required if patients experience signs indicative of severe adverse events. Signs of Serotonin Syndrome include hyperthermia, severe agitation, neuromuscular hyperexcitability, rigidity, diaphoresis, hyperreflexia, and altered mental status. Urgent medical attention is also necessary if manifestations of anaphylaxis occur, such as facial or lip swelling, skin rash, hives, or difficulty breathing. Furthermore, sudden emergence of suicidal ideation, severe panic attacks, symptoms of abnormal bleeding, or seizure activity requires immediate emergency medical evaluation.
Storage and expiration
Sarafem should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with temporary excursions permitted between 15°C and 30°C (59°F to 86°F). The medication must be kept in its original container, tightly closed, and protected from light and excess moisture. Storage in high-humidity areas such as bathrooms is not recommended. Keep out of reach of children and household pets. Do not use medication beyond the expiration date printed on the prescription label or packaging.
Common questions
Is Sarafem identical to Prozac?
Both Sarafem and Prozac contain the same active pharmaceutical ingredient, fluoxetine hydrochloride. However, Sarafem was specifically approved by the FDA with indications and dosing schedules tailored for Premenstrual Dysphoric Disorder (PMDD), whereas Prozac is indicated primarily for conditions such as Major Depressive Disorder and Obsessive-Compulsive Disorder. Patients should take the exact formulation prescribed by their healthcare provider.
How long does it take for Sarafem to show clinical improvement in PMDD?
Unlike the treatment of major depression, which often requires several weeks of continuous SSRI administration for therapeutic effect, Sarafem frequently provides noticeable relief of PMDD symptoms during the first treatment cycle. Clinical response may occur within days of initiating therapy during the luteal phase.
Can Sarafem therapy be stopped abruptly?
While fluoxetine has a long elimination half-life that buffers against sudden discontinuation reactions compared to shorter-acting SSRIs, abrupt cessation should still be managed under medical supervision. Prescribing clinicians may recommend a gradual tapering regimen to prevent potential discontinuation symptoms such as dizziness, mood fluctuations, or sensory disturbances.
Does Sarafem impair the ability to drive or operate machinery?
Central nervous system active drugs like Sarafem may impair judgment, thinking, or motor skills. Patients should assess their individual response to the medication, particularly regarding drowsiness or dizziness, before operating hazardous machinery or driving a motor vehicle.
What steps are necessary if pregnancy occurs during treatment?
If pregnancy occurs or is planned during treatment, the prescribing physician must be contacted promptly. The clinician will weigh the clinical benefits of continuing therapy against potential risks of exposure to the fetus, particularly during late pregnancy when risks of neonatal complications increase.
In accordance with FDA requirements.
This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.
Additional information
| Dosage |
10mg ,20mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Alkeran
$ 112,00 – $ 513,00Price range: $ 112,00 through $ 513,00
Active substance: Melphalan
More Details
This product has multiple variants. The options may be chosen on the product page
Altraz
$ 194,00 – $ 441,00Price range: $ 194,00 through $ 441,00
Active substance: Anastrozole
More Details
This product has multiple variants. The options may be chosen on the product page
Aygestin
$ 58,00 – $ 290,00Price range: $ 58,00 through $ 290,00
Active substance: Norethindrone
More Details
This product has multiple variants. The options may be chosen on the product page
Calcium Carbonate
$ 41,00 – $ 535,00Price range: $ 41,00 through $ 535,00
Active substance: Calcium Carbonate
More Details
This product has multiple variants. The options may be chosen on the product page
Diane 35
$ 16,00 – $ 46,00Price range: $ 16,00 through $ 46,00
Active substance: Cyproterone Acetate, Ethyl Estradiol
More Details
This product has multiple variants. The options may be chosen on the product page
Estriol
$ 64,00 – $ 137,00Price range: $ 64,00 through $ 137,00
Active substance: Estriol
More Details
This product has multiple variants. The options may be chosen on the product page
Female Cialis
$ 20,00 – $ 340,00Price range: $ 20,00 through $ 340,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Female Viagra
$ 41,00 – $ 305,00Price range: $ 41,00 through $ 305,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
